Froedtert: employee religious exemptions from COVID-19 vaccine are no longer legitimate
Some Medications Also Tied to Religious Vaccine Exemption
The hospital’s form includes a list of 30 common medications that used fetal cell lines during research and development. The list includes acetaminophen, albuterol, aspirin, ibuprofen, Tylenol, Pepto Bismol, Tums, Lipitor, Senokot, Motrin, Maalox, Ex-Lax, Benadryl, Sudafed, Preparation H, Claritin, Prilosec, and Zoloft.
Employees are asked to attest that they “truthfully acknowledge and affirm that my sincerely held religious belief is consistent and true” and that they won’t use the medications listed.
UK’s New Prime Minister Makes No Apologies for Favoring the Wealthy
Truss also went out of her way to channel Britain’s first female prime minister, Margaret Thatcher, who remains as iconic among the Tory Party base as Ronald Reagan is for Republicans in the U.S. Truss has studied Thatcher’s body language, has adopted her dress style — as Twitter users were quick to point out — and has reached for many of the same rhetorical tools. Yet, style notwithstanding, she has nowhere near the ideological consistency or heft of a Thatcher.
It will take all of Truss’s shape-shifting talents, and then some, to turn around the election ship for the Conservatives over the coming two years, which is the time span that Truss has before the next general election must be called. In the meantime, as the U.K. grapples with a deepening economic crisis, all of the new prime minister’s public statements suggest that the country is going to be dragged ever-further rightward into a deregulated, anti-union, Brexit-hued future.
God Save The UK!
VERIFY: New COVID booster approved from final study of mice, not humans
According to documents on the CDC website, human tests of Moderna’s version of the new booster are still “ongoing.” Right now, there is only final evidence from “8-10 mice” per group.”
The FDA’s website shows for Pfizer the agency also relayed on the final study evidence from “8 mice.” But human trials are also ongoing. So far, the new boosters “showed a similar local reaction and systemic event profile.” That means side effects appear to be about the same including “mild to moderate injection site pain, fatigue, and muscle pain.”
“To advance the Omicron BA.4/BA.5 bivalent vaccine as rapidly as possible, regulators, including the FDA, WHO and EMA, have advised that our submissions be based on safety and immunogenicity data generated in adults with an Omicron BA.1 bivalent vaccine and supported by BA.4/BA.5 bivalent pre-clinical data and BA.4/BA.5 bivalent quality and manufacturing data. These packages follow a similar model to that provided to public health officials who evaluate seasonal flu vaccines each year. Moving forward, this approach may help address the pressing need for vaccines that provide a high level of protection against current and emerging variants of concern so that we can remain vigilant against this evolving virus. The FDA has authorized our Omicron BA.4/BA.5 bivalent vaccine based on clinical data generated in adults with an Omicron BA.1 bivalent vaccine, pre-clinical data with a BA.4/BA.5 bivalent vaccine and BA.4/BA.5 bivalent quality and manufacturing data. Pre-clinical data showed a booster dose of Pfizer and BioNTech’s Omicron BA.4/BA.5- bivalent vaccine generated a strong neutralizing antibody response against Omicron BA.1, BA.2 and BA.4/BA.5 variants, as well as the original wild-type strain. A clinical study investigating the safety, tolerability and immunogenicity of the Omicron BA.4/BA.5 bivalent vaccine in individuals 12 years of age and older is ongoing. Data will be shared with regulators when available. We are facing a virus with an exceptionally high mutation rate, which the nimble mRNA platform is well situated to address. Only the mRNA sequence requires updating to match emerging strains, and utilizing a bivalent vaccine aims to provide broader coverage against known and future COVID-19 variants of concern.”
Read More »
Ads for climate-damaging meat set to be banned in this Dutch city
The ban, which it’s hoped will come into force in 2024, aims to reduce meat consumption and the impacts of the climate crisis.
It follows similar prohibitions by other Dutch cities on advertising from fossil fuel and aviation companies.
Netherlands turns to coal, renewables as gas usage falls